JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.

Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Journal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.

FARMACIA HOSPITALARIA, published by Elsevier Science Inc, is a premier open access journal that has been contributing to the fields of Medicine and Pharmacology since its inception in 1990. Based in the Netherlands, this journal provides a vital platform for the dissemination of high-quality research related to hospital pharmacy practice, medication management, and therapeutic outcomes. With an impressive scope that bridges clinical and pharmaceutical sciences, it positions itself within the 3rd quartile of both Medicine (miscellaneous) and Pharmacology categories, showcasing its relevance and evolving contributions to healthcare discourse. Since adopting an open access model in 2005, FARMACIA HOSPITALARIA has committed to making its research widely available, facilitating knowledge sharing among professionals and academics alike. Researchers and practitioners looking to stay updated with the latest advancements in pharmacy and clinical practices will find this journal an indispensable resource.

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

The European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.

The JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, published by Elsevier, serves as a pivotal resource for professionals and researchers in the field of pharmacology and pharmacy. With an impressive 2023 impact factor and classification in the top quartiles (Q1 and Q2) of pharmacology and nursing, this journal is recognized for its high-quality research and contributions that shape contemporary pharmaceutical practices. This journal addresses a broad spectrum of topics within the pharmaceutical sciences, offering insights into the latest advancements in medication management, patient care, and health policy. As a trusted platform for disseminating knowledge, it aims to enhance the professional development of pharmacists and pharmacy practitioners. By maintaining rigorous peer-review standards and a commitment to the dissemination of innovative research, the journal plays a crucial role in advancing the field of pharmacy and improving health outcomes on a global scale.